Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zile

Showing results (901-910 of 1,060) with videos related to

Pageof 106
Sort By:
JACC. Heart Failure|October 4, 2024
Natriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection FractionBrendon L Neuen, Muthiah Vaduganathan, Brian L Claggett, et al.
The Lancet Regional Health. Europe|September 24, 2021
International versus national growth charts for identifying small and large-for-gestational age newborns: A population-based study in 15 European countriesAlice Hocquette, Mélanie Durox, Rachael Wood, et al.
Circulation. Heart Failure|March 3, 2025
Impact of Multimorbidity on Mortality in Heart Failure With Mildly Reduced and Preserved Ejection FractionMingming Yang, Toru Kondo, Pooja Dewan, et al.
Journal of Cardiac Failure|October 4, 2015
How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) TrialAlan S Maisel, Kevin S Shah, Denise Barnard, et al.
European Journal of Heart Failure|August 21, 2014
Impaired left atrial function in heart failure with preserved ejection fractionAngela B S Santos, Elisabeth Kraigher-Krainer, Deepak K Gupta, et al.
Circulation|June 27, 2023
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?Toru Kondo, Pooja Dewan, Inder S Anand, et al.
Kidney International|July 3, 2019
Mitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injuryEhtesham Arif, Ashish K Solanki, Pankaj Srivastava, et al.
European Journal of Heart Failure|March 11, 2015
Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fractionSøren L Kristensen, Pardeep S Jhund, Lars Køber, et al.
Journal of the American College of Cardiology|April 8, 2024
Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart FailureSafia Chatur, Brendon L Neuen, Brian L Claggett, et al.
Cell Metabolism|March 3, 2026
Targeting microbiota-generated acetaldehyde to prevent progression of metabolic dysfunction-associated steatotic liver diseaseYajun Tang, Junliang Kuang, Xixi Xia, et al.
Pageof 106

Showing results (901-910 of 1,060) with videos related to

Sort By:
Pageof 106
JACC. Heart Failure|October 4, 2024
Natriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection FractionBrendon L Neuen, Muthiah Vaduganathan, Brian L Claggett, et al.
The Lancet Regional Health. Europe|September 24, 2021
International versus national growth charts for identifying small and large-for-gestational age newborns: A population-based study in 15 European countriesAlice Hocquette, Mélanie Durox, Rachael Wood, et al.
Circulation. Heart Failure|March 3, 2025
Impact of Multimorbidity on Mortality in Heart Failure With Mildly Reduced and Preserved Ejection FractionMingming Yang, Toru Kondo, Pooja Dewan, et al.
Journal of Cardiac Failure|October 4, 2015
How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) TrialAlan S Maisel, Kevin S Shah, Denise Barnard, et al.
European Journal of Heart Failure|August 21, 2014
Impaired left atrial function in heart failure with preserved ejection fractionAngela B S Santos, Elisabeth Kraigher-Krainer, Deepak K Gupta, et al.
Circulation|June 27, 2023
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?Toru Kondo, Pooja Dewan, Inder S Anand, et al.
Kidney International|July 3, 2019
Mitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injuryEhtesham Arif, Ashish K Solanki, Pankaj Srivastava, et al.
European Journal of Heart Failure|March 11, 2015
Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fractionSøren L Kristensen, Pardeep S Jhund, Lars Køber, et al.
Journal of the American College of Cardiology|April 8, 2024
Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart FailureSafia Chatur, Brendon L Neuen, Brian L Claggett, et al.
Cell Metabolism|March 3, 2026
Targeting microbiota-generated acetaldehyde to prevent progression of metabolic dysfunction-associated steatotic liver diseaseYajun Tang, Junliang Kuang, Xixi Xia, et al.
Pageof 106